Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
The Journal of Infectious Diseases
|
November 1, 2003
Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression
Dezso Virok, Andrey Loboda, Laszlo Kari, et al.
Journal of the National Cancer Institute
|
August 23, 2015
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics
Paul Geeleher, Andrey Loboda, Divya Lenkala, et al.
The Journal of Experimental Medicine
|
June 5, 2003
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma
Laszlo Kari, Andrey Loboda, Michael Nebozhyn, et al.
Blood
|
January 13, 2006
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy
Michael Nebozhyn, Andrey Loboda, Laszlo Kari, et al.
JCO Precision Oncology
|
April 23, 2025
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
JCO Precision Oncology
|
March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
BMC Medical Genomics
|
July 2, 2010
A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
Andrey Loboda, Michael Nebozhyn, Rich Klinghoffer, et al.
The Journal of Clinical Investigation
|
June 27, 2017
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers, Jared Lunceford, Michael Nebozhyn, et al.
Breast Cancer Research : BCR
|
March 12, 2025
Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study
Rebecca Dent, Javier Cortés, Yeon Hee Park, et al.
BMC Medical Genomics
|
February 11, 2009
Diurnal variation of the human adipose transcriptome and the link to metabolic disease
Andrey Loboda, Walter K Kraft, Bernard Fine, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
The Journal of Infectious Diseases
|
November 1, 2003
Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression
Dezso Virok, Andrey Loboda, Laszlo Kari, et al.
Journal of the National Cancer Institute
|
August 23, 2015
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics
Paul Geeleher, Andrey Loboda, Divya Lenkala, et al.
The Journal of Experimental Medicine
|
June 5, 2003
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma
Laszlo Kari, Andrey Loboda, Michael Nebozhyn, et al.
Blood
|
January 13, 2006
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy
Michael Nebozhyn, Andrey Loboda, Laszlo Kari, et al.
JCO Precision Oncology
|
April 23, 2025
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
JCO Precision Oncology
|
March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
BMC Medical Genomics
|
July 2, 2010
A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
Andrey Loboda, Michael Nebozhyn, Rich Klinghoffer, et al.
The Journal of Clinical Investigation
|
June 27, 2017
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers, Jared Lunceford, Michael Nebozhyn, et al.
Breast Cancer Research : BCR
|
March 12, 2025
Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study
Rebecca Dent, Javier Cortés, Yeon Hee Park, et al.
BMC Medical Genomics
|
February 11, 2009
Diurnal variation of the human adipose transcriptome and the link to metabolic disease
Andrey Loboda, Walter K Kraft, Bernard Fine, et al.
Page
of 4